{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-023296","form_type":"8-K","ticker":"BGMS","cik":"0001130166","company_name":"Bio Green Med Solution, Inc.","filed_at":"2025-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.406536+00:00","generated_at":"2026-05-17T13:51:47.849944+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cyclacel faces going concern warning; cash of $3.45M expected only into Q2 2025","bullets":["Auditor expresses substantial doubt about Cyclacel's ability to continue as a going concern; cash of $3.45M at March 31, 2025, expected to fund only into Q2 2025.","Net loss of $81k for Q1 2025 vs $2.9M in Q1 2024, largely due to a $4.9M gain from deconsolidation of UK subsidiary Cyclacel Limited on Jan 24, 2025.","Operating loss of $5.0M; R&D expenses fell to $822k from $2.8M, while G&A rose to $4.2M from $1.6M, partly due to $1.7M stock-based compensation.","Issued Series D and E preferred stock and converted shares; common shares outstanding surged from 8.9M to 207.3M during Q1 2025.","Regained Nasdaq compliance with equity rule on Feb 25, 2025; subject to one-year mandatory panel monitor."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-023296","json":"https://secwatch.observer/filing/0001641172-25-023296.json","markdown":"https://secwatch.observer/filing/0001641172-25-023296.md","text":"https://secwatch.observer/filing/0001641172-25-023296.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225023296/0001641172-25-023296-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225023296/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:51:47.849944+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}